Stock Earnings

Q: How is Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue broken down by segment or geography?

Shenzhen Hepalink Pharmaceutical Group Co Ltd largest revenue segment is Preparation, at a revenue of 2,986,074,622 in the most earnings release.For geography, Europe is the primary market for Shenzhen Hepalink Pharmaceutical Group Co Ltd, at a revenue of 2,372,845,163.

Question 1

What are Shenzhen Hepalink Pharmaceutical Group Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Shenzhen Hepalink Pharmaceutical Group Co Ltd has a total asset of $17,343, Net profit of $646

Question 2

What are the key financial ratios for SHEZF?

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltd's Current ratio is 3.33, has a Net margin is 12.23, sales per share of $3.59.

Question 3

How is Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue broken down by segment or geography?

Accepted Answer

SHEZF Financial

Shenzhen Hepalink Pharmaceutical Group Co Ltd

$0.46

0%

$0

At close: Jan 16, 16:00:00 GMT-5

$0.46

0%

$0

Post-market: Jan 16, 20:00:00 GMT-5

Overview Forecast Earnings Dividends Financials

Question 4

Is Shenzhen Hepalink Pharmaceutical Group Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Shenzhen Hepalink Pharmaceutical Group Co Ltd has a net profit of $646

Question 5

Does Shenzhen Hepalink Pharmaceutical Group Co Ltd have any liabilities?

Accepted Answer

yes, Shenzhen Hepalink Pharmaceutical Group Co Ltd has liability of 5,194

Question 6

How many outstanding shares for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltd has a total outstanding shares of 1,467.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5,406	5,280	5,445	7,159	6,365	5,332
Revenue Growth (YoY)	-1%	-3%	-24%	12%	19%	15%
Cost of Revenue	3,722	3,532	4,501	4,863	4,367	3,300
Gross Profit	1,683	1,748	944	2,295	1,998	2,031
Selling, General & Admin	862	781	930	972	878	767
Research & Development	257	203	173	244	216	154
Operating Expenses	1,344	1,099	1,232	1,292	1,186	996
Other Non Operating Income (Expenses)	0	-14	-66	1	-4	-1
Pretax Income	480	726	-928	829	222	1,327
Income Tax Expense	82	101	-126	114	-11	306
Net Income	420	646	-783	727	240	1,024
Net Income Growth	-388%	-183%	-208%	202.99%	-77%	-3%
Shares Outstanding (Diluted)	1,467.29	1,467.29	1,467.29	1,467.29	1,467.29	1,467.3
Shares Change (YoY)	0%	0%	0%	0%	0%	18%
EPS (Diluted)	0.28	0.44	-0.53	0.49	0.16	0.7
EPS Growth	-387%	-183%	-208%	202%	-77%	-18%
Free Cash Flow	1,685	1,991	-46	-979	-200	-175
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	31.13%	33.1%	17.33%	32.05%	31.39%	38.09%
Operating Margin	6.27%	12.27%	-5.28%	14.01%	12.74%	19.41%
Profit Margin	7.76%	12.23%	-14.38%	10.15%	3.77%	19.2%
Free Cash Flow Margin	31.16%	37.7%	-0.84%	-13.67%	-3.14%	-3.28%
EBITDA	--	744	-188	1,095	911	1,136
EBITDA Margin	--	14.09%	-3.45%	15.29%	14.31%	21.3%
D&A For EBITDA	--	96	100	92	100	101
EBIT	339	648	-288	1,003	811	1,035
EBIT Margin	6.27%	12.27%	-5.28%	14.01%	12.74%	19.41%
Effective Tax Rate	17.08%	13.91%	13.57%	13.75%	-4.95%	23.05%

Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF) Price

SHEZF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

EPS (TTM)

Dividend yield

Market Cap

What is SHEZF?

SHEZF Income

Follow-Up Questions